Variants of the HIV-1 Tat protein exhibiting higher transcriptional
activation and stronger P-TEFb binding than wild-type Tat are provided.
In addition variants that can inhibit transcription activation by
wild-type Tat are provided. Nucleic acid sequences encoding these
variants, vectors and host cells for expression of these variants, and
antibodies raised against these variants are also provided. In addition,
methods for use of these variants and compositions containing these
variants as research tools, as diagnostic tools and in the treatment of
viral infections are provided.